Neurobehavioral outcomes in young adults with perinatally acquired HIV.
Adolescent
Adult
Aged
Antiretroviral Therapy, Highly Active
/ methods
Cognition
/ physiology
Cognition Disorders
/ epidemiology
Cognitive Dysfunction
/ complications
Female
HIV Infections
/ complications
Humans
Infant
Infectious Disease Transmission, Vertical
Male
Neuropsychiatry
Neuropsychological Tests
Surveys and Questionnaires
Young Adult
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
15 11 2020
15 11 2020
Historique:
pubmed:
11
8
2020
medline:
13
3
2021
entrez:
11
8
2020
Statut:
ppublish
Résumé
With combination antiretroviral therapy (cART), infants with perinatally acquired HIV (pHIV) are living into adolescence and adulthood. Worldwide, many have not received cART in the first years of life, and challenges of adolescence complicate transition to adulthood. Neurobehavioral outcomes in pHIV young adults (pHIVAd) are infrequently reported. To examine neurobehavioral characteristics of pHIVAd ages 21-30 years, and to compare them with age-matched young adults infected in the second or third decade of life (HIVagematch), and older adults with similar duration HIV disease (HIVOA). A comprehensive neuropsychological test battery and questionnaires to determine cognitive function and mood, and reviews of neuromedical and behavioral records were undertaken in three groups of 13 individuals each. Descriptive analysis and bivariate techniques were used for comparisons. Rates of cognitive impairment were highest in pHIVAd (85%) compared with HIVagematch (38%) and HIVOA (62%). pHIVAd had the worst scores in global cognition, speed of information processing, working memory, and verbal fluency (0.5--1.0 SD below other groups). There was a trend for higher rates of psychiatric dysfunction (predominantly mood disorders) in pHIVAd (85%) compared with HIV-agematch (46%) and HIVOA (54%). Only four pHIVAd reported employment or enrollment in school. Four had autoimmune disorders. These pHIVAd displayed high rates of cognitive, psychiatric, and autoimmune dysfunction, greater than age-matched or HIV duration-matched comparators. Although this small study is largely descriptive in nature, it suggests that a lack of cART in early life may result in long-term neurobehavioral and immune abnormalities manifesting into adulthood.
Sections du résumé
BACKGROUND
With combination antiretroviral therapy (cART), infants with perinatally acquired HIV (pHIV) are living into adolescence and adulthood. Worldwide, many have not received cART in the first years of life, and challenges of adolescence complicate transition to adulthood. Neurobehavioral outcomes in pHIV young adults (pHIVAd) are infrequently reported.
OBJECTIVES
To examine neurobehavioral characteristics of pHIVAd ages 21-30 years, and to compare them with age-matched young adults infected in the second or third decade of life (HIVagematch), and older adults with similar duration HIV disease (HIVOA).
METHODS
A comprehensive neuropsychological test battery and questionnaires to determine cognitive function and mood, and reviews of neuromedical and behavioral records were undertaken in three groups of 13 individuals each. Descriptive analysis and bivariate techniques were used for comparisons.
RESULTS
Rates of cognitive impairment were highest in pHIVAd (85%) compared with HIVagematch (38%) and HIVOA (62%). pHIVAd had the worst scores in global cognition, speed of information processing, working memory, and verbal fluency (0.5--1.0 SD below other groups). There was a trend for higher rates of psychiatric dysfunction (predominantly mood disorders) in pHIVAd (85%) compared with HIV-agematch (46%) and HIVOA (54%). Only four pHIVAd reported employment or enrollment in school. Four had autoimmune disorders.
CONCLUSION
These pHIVAd displayed high rates of cognitive, psychiatric, and autoimmune dysfunction, greater than age-matched or HIV duration-matched comparators. Although this small study is largely descriptive in nature, it suggests that a lack of cART in early life may result in long-term neurobehavioral and immune abnormalities manifesting into adulthood.
Identifiants
pubmed: 32773479
doi: 10.1097/QAD.0000000000002655
pmc: PMC7606727
mid: NIHMS1619096
pii: 00002030-202011150-00011
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2081-2088Subventions
Organisme : NINR NIH HHS
ID : R21 NR015009
Pays : United States
Organisme : NIMH NIH HHS
ID : U24 MH100931
Pays : United States
Références
J Clin Exp Neuropsychol. 2004 Sep;26(6):759-78
pubmed: 15370374
Pediatrics. 2006 Mar;117(3):851-62
pubmed: 16510667
AIDS Care. 2020 Jan;32(1):21-29
pubmed: 31174426
J Int Neuropsychol Soc. 2004 May;10(3):317-31
pubmed: 15147590
Neurology. 2007 Oct 30;69(18):1789-99
pubmed: 17914061
AIDS. 2019 Jan 27;33(1):67-75
pubmed: 30325765
Clin Epigenetics. 2016 Sep 20;8:99
pubmed: 27660665
Curr Opin Neurol. 2005 Apr;18(2):117-23
pubmed: 15791140
J Int AIDS Soc. 2013 Jun 18;16:18593
pubmed: 23782478
J Int AIDS Soc. 2019 Apr;22(4):e25278
pubmed: 30990969
AIDS. 2019 Mar 15;33(4):597-603
pubmed: 30531318
Pediatr Infect Dis J. 2013 May;32(5):501-8
pubmed: 23263176
Rev Med Virol. 2014 Sep;24(5):316-31
pubmed: 24806816
Pediatr Infect Dis J. 2012 Jun;31(6):592-8
pubmed: 22592486
AIDS. 2012 Aug 24;26(13):1685-90
pubmed: 22614886
AIDS Patient Care STDS. 2009 Jun;23(6):415-21
pubmed: 19415986
J Acquir Immune Defic Syndr. 2010 Sep;55(1):134-6
pubmed: 20733406
J Neuroimmune Pharmacol. 2012 Dec;7(4):981-90
pubmed: 23065459
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Immunity. 2018 Sep 18;49(3):397-412
pubmed: 30231982
Front Immunol. 2014 Aug 27;5:393
pubmed: 25221551
AIDS Care. 2018 Jun;30(6):727-733
pubmed: 29336591
J Int Neuropsychol Soc. 2012 Jul;18(4):657-68
pubmed: 22621973
Clin Infect Dis. 2015 Apr 1;60(7):1111-9
pubmed: 25516183
Eur J Paediatr Neurol. 2008 Jul;12(4):290-7
pubmed: 17950012
J Child Psychol Psychiatry. 2009 Sep;50(9):1131-8
pubmed: 19298479
Brain Imaging Behav. 2017 Jun;11(3):649-665
pubmed: 27011015
Pediatrics. 2016 Nov;138(5):
pubmed: 27940772
Curr Opin Neurobiol. 2017 Dec;47:121-130
pubmed: 29080445
Clin Infect Dis. 2016 Nov 15;63(10):1380-1387
pubmed: 27581764
Vulnerable Child Youth Stud. 2018;13(2):158-169
pubmed: 30344614
J Int AIDS Soc. 2013 Jun 18;16:18603
pubmed: 23782482
Pediatrics. 2018 Feb;141(2):
pubmed: 29374109
AIDS Care. 2017 Mar;29(3):387-393
pubmed: 27690617
PLoS One. 2017 Aug 9;12(8):e0182415
pubmed: 28793310
Science. 2018 Oct 12;362(6411):185-189
pubmed: 30309946
AIDS Care. 2012;24(8):953-62
pubmed: 22519762
PLoS Pathog. 2012 Dec;8(12):e1003094
pubmed: 23300446